US 9610324
Apolipoprotein mixtures
granted A61KA61K38/1709A61K9/0019
Quick answer
US patent 9610324 (Apolipoprotein mixtures) held by Esperion Therapeutics, Inc. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Esperion Therapeutics, Inc.
- Grant date
- Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 60
- CPC classes
- A61K, A61K38/1709, A61K9/0019, A61P, A61P9/00